pd 98059 has been researched along with pyrazines in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebert, B; Lampen, A; Seidel, A | 1 |
| Chen, HP; He, M; Huang, QR; Liu, D; Zeng, GH | 1 |
| Fang, Y; He, Q; Jing, H; Luo, P; Song, H; Yang, B; Zhong, L; Zhou, X | 1 |
| Amin, HM; Chen, Z; He, Y; Shen, C; Song, YH; Wang, Y; Wu, D; Xing, S; Yang, S; Yue, Y | 1 |
4 other study(ies) available for pd 98059 and pyrazines
| Article | Year |
|---|---|
Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists.
Topics: Adenocarcinoma; Anticarcinogenic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzo(a)pyrene; Biological Transport; Cell Line, Tumor; Colonic Neoplasms; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Neoplasm Proteins; Polychlorinated Dibenzodioxins; Pyrazines; Receptors, Aryl Hydrocarbon; Reserpine; RNA, Messenger; Thiones; Thiophenes | 2005 |
Delayed protection of tetramethylpyrazine on neonatal rat cardiomyocytes subjected to anoxia-reoxygenation injury.
Topics: Alkaloids; Animals; Benzophenanthridines; Cell Survival; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glutathione Peroxidase; HSP70 Heat-Shock Proteins; In Vitro Techniques; L-Lactate Dehydrogenase; Malondialdehyde; Myocardial Reperfusion Injury; Myocytes, Cardiac; Protein Kinase C; Pyrazines; Rats; Superoxide Dismutase; Vasodilator Agents | 2007 |
Involvement of mitogen-activated protein kinase in signal transducer and activator of transcription-1 mediated differentiation induced by bortezomib in acute myeloid leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Differentiation; Cell Proliferation; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; MAP Kinase Signaling System; Phosphorylation; Pyrazines; STAT1 Transcription Factor; Tumor Cells, Cultured | 2013 |
Reversal of bortezomib resistance in myelodysplastic syndrome cells by MAPK inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Bone Marrow Cells; Boronic Acids; Bortezomib; Butadienes; Cell Cycle Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Flavonoids; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Nitriles; Nuclear Proteins; Proteasome Inhibitors; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazines | 2014 |